Recombinant tegumental protein Shistosoma japonicum very lowdensity lipoprotein binding protein as a vaccine candidate against Schistosoma japonicum

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 1, 2006, Pages 9-13

  Gan, Xiao Xian ^a   Shen, Li Ying ^a   Wang, Yue ^a   Ding, Jan Zu ^a   Shen, Hui Ying ^a   Zeng, Xiao Peng ^a   Pmcmanus, Donald ^b   Brindley, Paul J ^c   Fan, Jinjiang ^d  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Schistosoma japonicum; Schistosoma japonicum very lowdensity lipoprotein binding protein; Vaccine

Indexed keywords

ESCHERICHIA COLI; SCHISTOSOMA JAPONICUM;

EID: 33644507474     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000100003     Document Type: Article

References (31)

1. Abath FG, Werkhauser RC 1996. The tegument of Schislosoma mansoni. functional and immunological features. Parasite Immunol 18: 15-20.
2. Acosta LP, McManus DP, Aligui GD, Olveda RM, Tiu WU 2004. Antigen-specific antibody isotype patterns to Schistosoma japonicum recombinant and native antigens in a defined population in Leyte, the Philippines. Am J Trop Med Hyg 70: 549-555.
3. Acosta LP, Waine G, Aligui GD, Tiu WU, Olveda RM, McManus DP 2002. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop 84: 137-149.
4. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R 2003. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 88: 117-130.
5. Bergquist NR, Leonardo LR, Mitchell GF 2005. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21: 112-117.
6. Bergquist R, Al-Sherbiny M, Barakat R, Olds R 2002. Blue-print for schistosomiasis vaccine development. Acta Trop 82: 183-192.
7. Chitsulo L, Loverde P, Engels D 2004. Schistosomiasis. Nat Rev Microbiol 2: 12-13.
8. Capron M, Capron A, Abdel-Hafez. SK, Bazin H, Joseph M, Phillips SM 1983. Immunologic response of athymic rats to Schistosoma mansoni infection. II. Antibody-dependent mechanisms of resistance. J Immunol 131: 1475-1480.
9. Capron A, Riveau G, Capron M, Trottein F 2005. Related articles, schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 21:143-149.
10. Cioli D, Botros SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, Tchuente LA, Pica-Mattoccia L, Troiani AR, El-Din SH, Sabra AN, Albin J, Engels D, Doenhoff M.T 2004. Determination of ED50 values for praziquantel in praziquantel-resistant and -susceptible Schistosoma mansoni isolates,. Int J Parasitol 34: 979-87.
11. Dupre L, Poulain-Godefroy O, Ban E, Ivanoff N, Mekranfar M, Schacht AM, Capron A, Riveau G 1997. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol 19: 505-513.
12. Engels D, Chitsulo L, Montresor A, Savioli L2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82: 139-146.
13. Fan J, Gan X, Yang W, Shen L, McManus DP, Brindley PJ 2003. A Schistosoma japonicum very low-density lipoprotein-binding protein, Int J Biochem Cell Biol 35: 1436-1451.
14. Fan J, Minchella DJ, Day SR, McManus DP, Tiu WU, Brindley PJ 1998. Generation, identification, and evaluation of expressed sequence tags from different developmental stages of the Asian blood fluke Schistosoma japonicum. Biochem Biophys Res Commun 252: 348-356.
15. Fonseca CT, Brito CF, Alves JB, Oliveira SC 2004. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22: 503-510.
16. Horta MF, Ramalho-Pinto FJ 1984. Subclasses of rat IgG active in the killing of schistosomula of Schistosoma mansoni in vitro and in vivo. J Immunol 133: 3326-3332.
17. Horta MF, Ramalho-Pinto FJ 1987. Levels of lethal antibody during the course of infection with Schistosoma mansoni in rats and mice. Mem Inst Oswaldo Cruz 82 (Suppl. 4): 283-284.
18. Hu W, Yan Q, Shen DK, Liu F, Zhu ZD, Song HD, Xu XR, Wang ZJ, Rong YP, Zeng LC, Wu J, Zhang X, Wang JJ, Xu XN, Wang SY, Fu G, Zhang XL, Wang ZQ, Brindley PJ, McManus DP, Xue CL, Feng Z, Chen Z, Han ZG 2003. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 35: 139-147.
19. Jones MK, Gobert GN, Zhang L, Sunderland P, McManus DP 2004. The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and hostparasite interactions. Bioessays 26: 752-765.
20. Katz N, Chaves A, Pellegrino J 1972. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 14: 397-400.
21. Liu SX, Song GC, Xu YX, Yang W, McManus DP 1995. Immunization of mice with recombinant Sjc26GST induces a pronounced antifecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 13: 603-607.
22. Markwell M A, Haas SM, Bieber LL, Tolbert NE 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210.
23. McManus DP 2005. Prospects for development of a transmission blocking vaccine against Schistosoma japonicum. Parasite Immunol 27: 297-308.
24. McManus DP, Bartley PB 2004. A vaccine against Asian schistosomiasis. Parasitol Int 53: 163-173.
25. Mountford AP, Fisher A, Wilson RA 1994. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni. Parasite Immunol 16: 521-527.
26. Pearce EJ 2003. Progress towards a vaccine for schistosomiasis. Acta Trop 86: 309-313.
27. Ribeiro de Jesus A, Araujo I, Bacellar O, Magalhaes A, Pearce E, Harn D, Strand M, Carvalho EM 2000. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun 68: 2797-2803.
28. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP 2002. Schistosomiasis. N Engl J Med 346: 1212-1220.
29. Ruppel A, Shi YE, Moloney NA 1990. Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae. Parasitology 101: 23-26.
30. Siddiqui AA, Phillips T, Charest H, Podesta RB, Quinlin ML, Pinkston JR, Lloyd .ID, Pompa J, Villalovos RM, Paz M 2003. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 21:2882-2889.
31. Snapper CM, Paul WE 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.